CELLULAR FACTORS INVOLVED IN NUCLEAR EXPORT OF VIRAL RNA
CELLULAR FACTORS INVOLVED IN NUCLEAR EXPORT OF VIRAL RNA
批准号:
2857303
负责人:
Flossie Wong-Staal
金额:
$19.5万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-01-01 至 2001-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from Applicant's Abstract) The HIV Rev protein
differtially controls viral protein expression post-transcriptionally. Rev
and its cognate RNA, RRE, likely interface with cellular components that are
involved in cellular post-transciptional gene regulation. A cis-acting,
constitutive transport element (CTE) from type-D retroviruses is able to
substitute for REV function. It is not clear if and when the pathways
involved in REv- and CTE-mediated RNA transport converge. Elucidation of
these processes will shed light on fundamental aspects of cellular transport
mechanisms and may be important for development of antiviral strategies.
They have previously identified and partially purified two proteins of 40 Kd
and 65 Kd that specifically bind to functional CTE RNA. More recently, they
have identified an additional, high molecular weight protein that also binds
to functional CTE RNA. They have further purified this protein and obtained
a partial sequence, which completely matched that of RNA Helicase A (Hel A).
They then obtained the complete DNA clone, and found that although Hel A is
normally localized predominantly in the nucleus, it shuttles to the
cytoplasm in the presence of functional CTE RNA or expression of both REv
and RRE. That RNA Helicase A can be a shuttle protein is a novel discovery.
The major goal of proposal is to isolate and functionally characterize CTE
binding proteins and to define their role in CTE-anad REv- mediated
pathways. Their specific aims are: (i) To functionally characterize the
role of RNA Helicase A in viral mRNA transport - They will map the binding
domains of Hel A and CTE RNA, and determine if mutations that affect CTEBP
binding will also affect its helicase activity or its ability to shuttle in
response to CTE. (ii) To determine if Hel A functions broadly in the
post-transcriptional regulation of viral mRNA - We will determine if HEL A
physically interacts with the Rev and RRE complex, and if it responds to
other RNA nuclear export elements (e.g. the PRE of hepatitis virus) or other
retroviral RNA. (iii) To clone and characterize genes for the 40 Kd and 65
Kd CTE binding proteins - Both proteins have been partially purified. They
will determine partial amino acid sequences of these proteins to derive
probe for cDNA cloning. The relevance of the derived cDNA to CTE or Rev and
RRE function will be determined. (iv) To determine the relevance of
specific cellular proteins in REV- or CTE-mediated transactivation, using
ribozyme inactivation- We will design conditional expresssion vectors for
ribozymes targeting the CTEBP genes as well as published Rev and RRE binding
cellular genes, and determine if inactivation of these genes by ribozmes
will impact on both Rev- and CTE-mediated gene expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of the Potential Anti-Diabetic Activity of ITX2158 In Vivo
-
批准号:7608527
-
项目类别:
-
资助金额:$15.32万
-
财政年份:2009
-
负责人:Flossie Wong-Staal
-
依托单位:
Development of HIV vectors for antiviral and immune based therapies
-
批准号:6642250
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2002
-
负责人:Flossie Wong-Staal
-
依托单位:
Development of HIV vectors for antiviral and immune based therapies
-
批准号:6484680
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2001
-
负责人:Flossie Wong-Staal
-
依托单位:
Development of HIV vectors for antiviral and immune based therapies
-
批准号:6336287
-
项目类别:
-
资助金额:$20.81万
-
财政年份:2000
-
负责人:Flossie Wong-Staal
-
依托单位:
Development of HIV vectors for antiviral and immune based therapies
-
批准号:6224439
-
项目类别:
-
资助金额:$20.81万
-
财政年份:1999
-
负责人:Flossie Wong-Staal
-
依托单位:
Development of HIV vectors for antiviral and immune based therapies
-
批准号:6314013
-
项目类别:
-
资助金额:$20.81万
-
财政年份:1999
-
负责人:Flossie Wong-Staal
-
依托单位:
LENTIVIRAL VECTORS FOR HIV GENE THERAPY
-
批准号:6312137
-
项目类别:
-
资助金额:$7.42万
-
财政年份:1999
-
负责人:Flossie Wong-Staal
-
依托单位:
CONFERENCE ON AIDS PATHOGENESIS
-
批准号:2724652
-
项目类别:
-
资助金额:$2.8万
-
财政年份:1999
-
负责人:Flossie Wong-Staal
-
依托单位:
LENTIVIRAL VECTORS FOR HIV GENE THERAPY
-
批准号:6374258
-
项目类别:
-
资助金额:$74.74万
-
财政年份:1999
-
负责人:Flossie Wong-Staal
-
依托单位:
LENTIVIRAL VECTORS FOR HIV GENE THERAPY
-
批准号:6170615
-
项目类别:
-
资助金额:$74.79万
-
财政年份:1999
-
负责人:Flossie Wong-Staal
-
依托单位:
LENTIVIRAL VECTORS FOR HIV GENE THERAPY
-
批准号:2909181
-
项目类别:
-
资助金额:$62.43万
-
财政年份:1999
-
负责人:Flossie Wong-Staal
-
依托单位:
RIBOZYME GENE THERAPY FOR CD4 AND CD34 CELLS
-
批准号:6177741
-
项目类别:
-
资助金额:$26.7万
-
财政年份:1998
-
负责人:Flossie Wong-Staal
-
依托单位:
RIBOZYME GENE THERAPY FOR CD4 AND CD34 CELLS
-
批准号:2906318
-
项目类别:
-
资助金额:$25.99万
-
财政年份:1998
-
负责人:Flossie Wong-Staal
-
依托单位:
RIBOZYME GENE THERAPY FOR HIV-1 INFECTION
-
批准号:6117937
-
项目类别:
-
资助金额:$1.46万
-
财政年份:1998
-
负责人:Flossie Wong-Staal
-
依托单位:
CELLULAR FACTORS INVOLVED IN NUCLEAR EXPORT OF VIRAL RNA
-
批准号:6138576
-
项目类别:
-
资助金额:$19.89万
-
财政年份:1998
-
负责人:Flossie Wong-Staal
-
依托单位:
RIBOZYME GENE THERAPY FOR CD4 AND CD34 CELLS
-
批准号:6381270
-
项目类别:
-
资助金额:$27.44万
-
财政年份:1998
-
负责人:Flossie Wong-Staal
-
依托单位:
CELLULAR FACTORS INVOLVED IN NUCLEAR EXPORT OF VIRAL RNA
-
批准号:2543057
-
项目类别:
-
资助金额:$23.26万
-
财政年份:1998
-
负责人:Flossie Wong-Staal
-
依托单位:
CELLULAR FACTORS INVOLVED IN NUCLEAR EXPORT OF VIRAL RNA
-
批准号:6342950
-
项目类别:
-
资助金额:$20.29万
-
财政年份:1998
-
负责人:Flossie Wong-Staal
-
依托单位:
RIBOZYME GENE THERAPY FOR CD4 AND CD34 CELLS
-
批准号:2720290
-
项目类别:
-
资助金额:$26.24万
-
财政年份:1998
-
负责人:Flossie Wong-Staal
-
依托单位:
RIBOZYME GENE THERAPY FOR HIV-1 INFECTION
-
批准号:6249144
-
项目类别:
-
资助金额:$1.64万
-
财政年份:1997
-
负责人:Flossie Wong-Staal
-
依托单位: